Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis

Oral Diseases

Volumn 11, Issue 6, 2005, Pages 392-398

  Campanha, N H ^a   Neppelenbroek, K H ^a   Spolidorio, Denise M P ^a   Spolidorio, L C ^a   Pavarina, A C ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Candida; Candida albicans; Candida dubliniensis; Candidiasis, oral; Isolation and purification; Pathology, oral

Indexed keywords

ANTIFUNGAL AGENT; MONOCLONAL ANTIBODY;

ARTICLE; BACTERIAL GROWTH; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CARBON SOURCE; ENZYME SYNTHESIS; FUSOBACTERIUM NUCLEATUM; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; THRUSH; YEAST;

CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, ORAL; CARBOHYDRATE METABOLISM; MYCOLOGICAL TYPING TECHNIQUES; PHENOTYPE; TEMPERATURE;

EID: 28444462116     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2005.01135.x     Document Type: Article

References (56)

1. Ahmad S, Khan Z, Mokaddas E et al (2004). Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait. J Med Microbiol 53: 633-637.
2. Ainscough S, Kibbler CC (1998). An evaluation of the cost-effectiveness of using CHROMagar for yeast identification in a routine microbiology laboratory. J Med Microbiol 47: 623-628.
3. Al Mosaid A, Sullivan D, Salkin IF et al (2001). Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol 39: 323-327.
4. Al Mosaid A, Sullivan DJ, Coleman DC (2003). Differentiation of Candida dubliniensis from Candida albicans on Pal's Agar. J Clin Microbiol 41: 4787-4789.
5. Alves SH, Milan EP, de Laet Sant'Ana P et al (2002). Hypertonic sabouraud broth as a simple and powerful test for Candida dubliniensis screening. Diagn Microbiol Infect Dis 43: 85-86.
6. Anson JJ, Allen KD (1997). Evaluation of CHROMagar Candida medium for the isolation and direct identification of yeast species from the female genital tract. Br J Biomed Sci 54: 237-239.
7. Bikandi J, Millan RS, Moragues MD et al (1998). Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J Clin Microbiol 36: 2428-2433.
8. Borg-von Zepelin M, Niederhaus T, Gross U et al (2002). Adherence of different Candida dubliniensis isolates in the presence of fluconazole. AIDS 16: 1237-1244.
9. Borst A, Theelen B, Reinders E et al (2003). Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis. J Clin Microbiol 41: 1357-1362.
10. Coleman DC, Sullivan DJ, Bennett DE et al (1997). Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11: 557-567.
11. Contreras I, San-Millan R, Agustin-Barrasa A et al (1996). Utility of Albicans ID plate for rapid identification of Candida albicans in clinical samples. Rapid identification of Candida albicans. Mycopathologia 136: 17-20.
12. Ellepola AN, Hurst SF, Elie CM et al (2003). Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods. Oral Microbiol Immunol 18: 379-388.
13. Espinel-Ingroff A, Stockman L, Roberts G et al (1998). Comparison of RapID Yeast Plus System with API 20C System for identification of common, new, and emerging yeast pathogens. J Clin Microbiol 36: 883-886.
14. Fotedar R, Al-Hedaithy SS (2003). Candida dubliniensis at a university hospital in Saudi Arabia. J Clin Microbiol 41: 1907-1911.
15. Freydiere AM, Guinet R, Boiron P (2001). Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med Mycol 39: 9-33.
16. Gales AC, Pfaller MA, Houston AK et al (1999). Identification of Candida dubliniensis based on temperature and utilization of xylose and methyl-α-D-glucoside as determined with the API 20C AUX and Vitek YBC Systems. J Clin Microbiol 37: 3804-3808.
17. Gilfillan GD, Sullivan DJ, Haynes K et al (1998). Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 144: 829-838.
18. Graf B, Adam T, Zill E et al (2000). Evaluation of the VITEK 2 system for rapid identification of yeasts and yeast-like organisms. J Clin Microbiol 38: 1782-1785.
19. Gugnani HC, Becker K, Fegeler W et al (2003). Oropharyngeal carriage of Candida species in HIV-infected patients in India. Mycoses 46: 299-306.
20. Gunasekaran M, Hughes WT (1980). Gas-liquid chromatography: a rapid method for identification of different species of Candida. Mycologia 72: 505-511.
21. Jabra-Rizk MA, Baqui AAMA, Kelley JI (1999a). Identification of Candida dubliniensis in a prospective study of patients in the United States. J Clin Microbiol 37: 321-326.
22. Jabra-Rizk MA, Falkler WA Jr, Merz WG et al (1999b). Coaggregation of Candida dubliniensis with Fusobacterium nucleatum. J Clin Microbiol 37: 1464-1468.
23. Jabra-Rizk MA, Falkler WA Jr, Merz WG et al (2000). Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J Clin Microbiol 38: 2423-2426.
24. Khan ZU, Ahmad S, Mokaddas E et al (2004). Simplified sunflower (Helianthus annuus) seed agar for differentiation of Candida dubliniensis from Candida albicans. Clin Microbiol Infect 10: 590-592.
25. Kitch TT, Jacobs MR, McGinnis MR (1996). Ability of RapID Yeast Plus System to identify 304 clinically significant yeasts within 5 hours. J Clin Microbiol 34: 1069-1071.
26. Lees E, Barton RC (2003). The use of Niger seed agar to screen for Candida dubliniensis in the clinical microbiology laboratory. Diagn Microbiol Infect Dis 46: 13-17.
27. Manfredi M, Al-Karaawi Z, McCullough MJ (2002). The isolation, identification and molecular analysis of Candida spp. Isolated from the oral cavities of patients with diabetes mellitus. Oral Microbiol Immunol 17: 181-185.
28. Marot-Leblond A, Grimaud L, Nail S et al (2000). New monoclonal antibody specific for Candida albicans germ tube. J Clin Microbiol 38: 61-67.
29. Martinez M, López-Ribot JL, Kirkpatrick WR et al (2002). Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal. J Clin Microbiol 40: 3135-3139.
30. Meis JFGM, Ruhnke M, De Pauw BE et al (1999). Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis 5: 150-153.
31. Moran GP, Sullivan DJ, Henman MC et al (1997). Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 41: 617-623.
32. Mosca CO, Moragues MD, Llovo J et al (2003). Casein agar: a useful medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 41: 1259-1262.
33. Odds FC, Bernaerts R (1994). CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 32: 1923-1929.
34. Peltroche-Llacsahuanga H, Schmidt S, Seibold M et al (2000). Differentiation between Candida dubliniensis and Candida albicans by fatty acid methyl ester analysis using gas-liquid chromatography. J Clin Microbiol 38: 3696-3704.
35. Perea S, Lopez-Ribot JL, Wickes BL et al (2002). Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob Agents Chemother 46: 1695-1703.
36. Pfaller MA, Houston A, Coffmann S (1996). Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol 34: 58-61.
37. Pfaller MA, Messer SA, Gee S et al (1999). In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol 37: 870-872.
38. Pincus DH, Coleman DC, Pruitt WR (1999). Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol 37: 3533-3539.
39. Ramage G, Walle KV, Wickes BL et al (2001). Biofilm formation by Candida dubliniensis. J Clin Microbiol 39: 3234-3240.
40. Ruhnke M, Schmidt-Westhausen A, Morschhauser J (2000). Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS. J Antimicrob Chemother 46: 291-295.
41. Salkin IF, Pruitt WR, Padhye AA et al (1998). Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered in the United States. J Clin Microbiol 36: 1467.
42. Sancak B, Rex JH, Paetznick V et al (2003). Evaluation of a method for identification of Candida dubliniensis blood-stream isolates. J Clin Microbiol 41: 489-491.
43. Sandven P (1990). Laboratory identification and sensitivity testing of yeast isolates. Acta Odontol Scand 48: 27-36.
44. Soil DR (2000). The ins and outs of DNA fingerprinting the infectious fungi. Clin Microbiol Rev 13: 332-370.
45. Staib P, Morschhauser J (1999). Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses 42: 521-524.
46. Sullivan D, Coleman D (1998). Candida dubliniensis: characteristics and identification. J Clin Microbiol 36: 329-334.
47. Sullivan DJ, Westerneng TJ, Haynes KA et al (1995). Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141: 1507-1521.
48. Sullivan D, Haynes K, Bille J et al (1997). Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol 35: 960-964.
49. Sullivan DJ, Moran GP, Pinjon E et al (2004). Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 4: 369-376.
50. Timmins EM, Howell SA, Alsberg BK et al (1998). Rapid differentiation of closely related Candida species and strains by pyrolysis-mass spectrometry and Fourier transform-infrared spectroscopy. J Clin Microbiol 36: 367-374.
51. Tintelnot K, Haase G, Seibold M et al (2000). Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 38: 1599-1608.
52. Velegraki A, Logotheti M (1998). Presumptive identification of an emerging yeast pathogen: Candida dubliniensis (sp. nov.) reduces 2,3,5-triphenyltetrazolium chloride. FEMS Immunol Med Microbiol 20: 239-241.
53. Williams DW, Lewis MAO (2000). Isolation and identification of Candida from the oral cavity. Oral Dis 6: 3-11.
54. Willinger B, Manafi M (1999). Evaluation of CHROM agar Candida for rapid screening of clinical specimens for Candida species. Mycoses 42: 61-65.
55. Willinger B, Hillowoth C, Selitsch B et al (2001). Performance of Candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROM agar Candida. Clin Microbiol 39: 3793-3795.
56. Xu J, Millar BC, Moore JE et al (2002). Comparison of API20C with molecular identification of Candida spp. isolated from bloodstream infections. J Clin Pathol 55: 774-777.